Evaluation of pharmaceutical intervention to patients in the community through telepharmacy

Delgado-Pérez G.M.; Munayco Ortiz X.N.; Chipana Lujan J.R.; Dávila-Espinoza C.E.; Pizarro-Herrera V.R. · Farmaceuticos Comunitarios (2025) · DOI: 10.33620/fc.2173-9218.(2025).33

Resumen

Introduction: Pharmaceutical interventions (PI) are important for the resolution of drug-related problems (DRP). An alternative to efficiently meet this need is telepharmacy, defined as a modality of pharmaceutical services provided remotely through information and communication technologies (ICT). Objectives: To evaluate PI through telepharmacy in terms of their benefit to treatment effectiveness and/or safety. Methods: Retrospective observational study. Data were obtained from the pharmacotherapeutic records of eight community pharmacies that carried out PI through telepharmacy from November 2020 to October 2021. PI were evaluated using impact codes (benefit to treatment effectiveness and/or safety). Results: A total of 21 patients participated, of whom 11 were men. The median age was 61 years (Q1–Q3: 55–67). According to the ATC code, the most prevalent drug groups were: A—Alimentary tract and metabolism (n=38; 24.2%) and C—Cardiovascular system (n=31; 19.8%). A total of 183 DRP were identified (90 potential and 93 actual) and 121 PI, of which 51.2% could be evaluated (n=62; 44 PI on effectiveness and 18 PI on safety). Conclusion: The PI carried out by community pharmacists were assessable and improved both the effectiveness and safety of medications.

Instituciones: Universidad Nacional Mayor de San Marcos